A Pre-Leukemic DNA Methylation Signature in Healthy Individuals Associated with Risk of Myeloid Malignancy
Methylation profiling by high throughput sequencing Overall design: We performed global DNA methylation profiling in a case-control study nested within Singapore Chinese Health Study to evaluate if DNA methylation alterations were associated with AML/MDS development. Targeted deep sequencing and methylated DNA immunoprecipitation sequencing (MeDIP-seq) were performed on peripheral blood collected a median of 9.9 years prior to diagnosis of AML or MDS, together with age-matched still healthy individuals as controls.